Kilitch Drugs (India) (NSE:KILITCH) Other Operating Expense : ₹654 Mil (TTM As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Kilitch Drugs (India) Other Operating Expense?

Kilitch Drugs (India)'s Other Operating Expense for the three months ended in Mar. 2025 was ₹184 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₹654 Mil.

Kilitch Drugs (India)'s quarterly Other Operating Expense declined from Sep. 2024 (₹174 Mil) to Dec. 2024 (₹155 Mil) but then increased from Dec. 2024 (₹155 Mil) to Mar. 2025 (₹184 Mil).

Kilitch Drugs (India)'s annual Other Operating Expense increased from Mar. 2023 (₹447 Mil) to Mar. 2024 (₹497 Mil) and increased from Mar. 2024 (₹497 Mil) to Mar. 2025 (₹654 Mil).

Kilitch Drugs (India) Other Operating Expense Historical Data

The historical data trend for Kilitch Drugs (India)'s Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kilitch Drugs (India) Other Operating Expense Chart

Kilitch Drugs (India) Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Other Operating Expense

Get a 7-Day Free Trial

234.22

322.60

447.23

497.33

653.84

Kilitch Drugs (India) Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															139.14	141.13	173.96	154.77	183.98

Kilitch Drugs (India) Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹654 Mil.

Kilitch Drugs (India) Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Kilitch Drugs (India)'s Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Kilitch Drugs (India) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kilitch Drugs (India) Ltd (NSE:KILITCH) » Definitions » Other Operating Expense

Traded in Other Exchanges

524500:India

Address

Waman Tukaram Patil Marg, 37/39, Ujagar Industrial Estate, Deonar, Mumbai, MH, IND, 400 088

Website

https://www.kilitch.com

Kilitch Drugs (India) Ltd is an India-based pharmaceutical company. It is engaged in the manufacture and sales of pharmaceutical products. The company offers parenteral and nasal products, oral formulations, effervescent tablets, nutritional products, medical devices, and cosmetic and health products. Some of the products offered by the company are Roipar, Roivit, PH-7, C-Seal, SRO kit, 9-VIT, HPURE, and others. The company has one reportable segment, which is the development and operations of the Pharmaceutical business.

Kilitch Drugs (India) Headlines

No Headlines